Radiology Personnel

Hedieh Khalatbari, M.D.

Assistant Professor
Pediatric Radiology

Biography

Dr.¬†Khalatbari is a pediatric radiologist at Seattle Children’s Hospital. She is board certified in both diagnostic radiology and nuclear medicine. Dr.¬†Khalatbari has completed fellowships in pediatric radiology and neuroradiology at Stanford Hospital.

Recent Publications

See all publications on Scopus

Initial treatment of pediatric differentiated thyroid cancer: a review of the current risk-adaptive approach
Parisi M.T., Khalatbari H., Parikh S.R., Alazraki A.
Pediatric Radiology. 2019 Oct:1391-1403

Utility of 18F-FDG PET/CT in Infantile Myofibromatosis
Tang E.R., Khalatbari H., Parisi M.T.
Clinical Nuclear Medicine. 2019 Aug:676-679

Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapy
Gust J., Finney O.C., Li D., Brakke H.M., Hicks R.M., Futrell R.B., Gamble D.N., Rawlings-Rhea S.D., Khalatbari H.K., Ishak G.E., Duncan V.E., Hevner R.F., Jensen M.C., Park J.R., Gardner R.A.
Annals of Neurology. 2019 Jul:42-54

Pediatric Musculoskeletal Imaging: The Indications for and Applications of PET/Computed Tomography
Khalatbari H., Parisi M.T., Kwatra N., Harrison D.J., Shulkin B.L.
PET Clinics. 2019 Jan:145-174

Two signs indicative of successful access in nuclear medicine cerebrospinal fluid diversionary shunt studies
Bermo M.S., Khalatbari H., Parisi M.T.
Pediatric Radiology. 2018 Aug:1130-1138

Pediatric Abdominal Infection and Inflammation: Choosing the Appropriate Diagnostic Imaging Study
Chapman T., Khalatbari H.
Journal of Pediatric Infectious Diseases. 2017 Mar:2-19

131I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications
Parisi M., Eslamy H., Park J., Shulkin B., Yanik G.
Seminars in Nuclear Medicine. 2016 May:184-202

Management of differentiated thyroid cancer in children: Focus on the American Thyroid Association pediatric guidelines
Parisi M., Eslamy H., Mankoff D.
Seminars in Nuclear Medicine. 2016 Mar:147-164

Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity
Roth C., Eslamy H., Werny D., Elfers C., Shaffer M., Pihoker C., Ojemann J., Dobyns W.
Obesity. 2015 Jun:1226-1233

Efficacy of cabazitaxel in mouse models of pediatric brain tumors
Girard E., Ditzler S., Lee D., Richards A., Yagle K., Park J., Eslamy H., Bobilev D., Vrignaud P., Olson J.
Neuro-Oncology. 2015 Jan:107-115